View in EDS HTML Full Text PDF Full Text

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.

Saved in:
Bibliographic Details
Title: Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
Authors: Pascal KE; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Dudgeon D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Trefry JC; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Anantpadma M; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Sakurai Y; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Murin CD; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California., Fairhurst J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Torres M; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Rafique A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Yan Y; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Badithe A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Yu K; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Potocky T; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Bixler SL; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Chance TB; Pathology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Pratt WD; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Rossi FD; Center for Aerobiological Sciences, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Shamblin JD; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Wollen SE; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Zelko JM; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Carrion R Jr; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Worwa G; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Staples HM; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Burakov D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Babb R; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Chen G; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Martin J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Huang TT; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Erlandson K; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Willis MS; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Armstrong K; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Dreier TM; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California., Davey RA; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio., Pitt MLM; Office of the Commander, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland., Lipsich L; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Mason P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Olson W; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Stahl N; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Kyratsous CA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Source: The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S612-S626.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29860496
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pascal+KE%22">Pascal KE</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Dudgeon+D%22">Dudgeon D</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Trefry+JC%22">Trefry JC</searchLink>; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Anantpadma+M%22">Anantpadma M</searchLink>; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.<br /><searchLink fieldCode="AU" term="%22Sakurai+Y%22">Sakurai Y</searchLink>; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.<br /><searchLink fieldCode="AU" term="%22Murin+CD%22">Murin CD</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Turner+HL%22">Turner HL</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Fairhurst+J%22">Fairhurst J</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Torres+M%22">Torres M</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Rafique+A%22">Rafique A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Yan+Y%22">Yan Y</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Badithe+A%22">Badithe A</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Yu+K%22">Yu K</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Potocky+T%22">Potocky T</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Bixler+SL%22">Bixler SL</searchLink>; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Chance+TB%22">Chance TB</searchLink>; Pathology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Pratt+WD%22">Pratt WD</searchLink>; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Rossi+FD%22">Rossi FD</searchLink>; Center for Aerobiological Sciences, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Shamblin+JD%22">Shamblin JD</searchLink>; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Wollen+SE%22">Wollen SE</searchLink>; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Zelko+JM%22">Zelko JM</searchLink>; Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Carrion+R+Jr%22">Carrion R Jr</searchLink>; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.<br /><searchLink fieldCode="AU" term="%22Worwa+G%22">Worwa G</searchLink>; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.<br /><searchLink fieldCode="AU" term="%22Staples+HM%22">Staples HM</searchLink>; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.<br /><searchLink fieldCode="AU" term="%22Burakov+D%22">Burakov D</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Babb+R%22">Babb R</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Chen+G%22">Chen G</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Martin+J%22">Martin J</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Huang+TT%22">Huang TT</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Erlandson+K%22">Erlandson K</searchLink>; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Willis+MS%22">Willis MS</searchLink>; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Armstrong+K%22">Armstrong K</searchLink>; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Dreier+TM%22">Dreier TM</searchLink>; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Ward+AB%22">Ward AB</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California.<br /><searchLink fieldCode="AU" term="%22Davey+RA%22">Davey RA</searchLink>; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio.<br /><searchLink fieldCode="AU" term="%22Pitt+MLM%22">Pitt MLM</searchLink>; Office of the Commander, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland.<br /><searchLink fieldCode="AU" term="%22Lipsich+L%22">Lipsich L</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Mason+P%22">Mason P</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Olson+W%22">Olson W</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Stahl+N%22">Stahl N</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.<br /><searchLink fieldCode="AU" term="%22Kyratsous+CA%22">Kyratsous CA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S612-S626.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29860496
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiy285
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: S612
    Titles:
      – TitleFull: Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pascal KE
      – PersonEntity:
          Name:
            NameFull: Dudgeon D
      – PersonEntity:
          Name:
            NameFull: Trefry JC
      – PersonEntity:
          Name:
            NameFull: Anantpadma M
      – PersonEntity:
          Name:
            NameFull: Sakurai Y
      – PersonEntity:
          Name:
            NameFull: Murin CD
      – PersonEntity:
          Name:
            NameFull: Turner HL
      – PersonEntity:
          Name:
            NameFull: Fairhurst J
      – PersonEntity:
          Name:
            NameFull: Torres M
      – PersonEntity:
          Name:
            NameFull: Rafique A
      – PersonEntity:
          Name:
            NameFull: Yan Y
      – PersonEntity:
          Name:
            NameFull: Badithe A
      – PersonEntity:
          Name:
            NameFull: Yu K
      – PersonEntity:
          Name:
            NameFull: Potocky T
      – PersonEntity:
          Name:
            NameFull: Bixler SL
      – PersonEntity:
          Name:
            NameFull: Chance TB
      – PersonEntity:
          Name:
            NameFull: Pratt WD
      – PersonEntity:
          Name:
            NameFull: Rossi FD
      – PersonEntity:
          Name:
            NameFull: Shamblin JD
      – PersonEntity:
          Name:
            NameFull: Wollen SE
      – PersonEntity:
          Name:
            NameFull: Zelko JM
      – PersonEntity:
          Name:
            NameFull: Carrion R Jr
      – PersonEntity:
          Name:
            NameFull: Worwa G
      – PersonEntity:
          Name:
            NameFull: Staples HM
      – PersonEntity:
          Name:
            NameFull: Burakov D
      – PersonEntity:
          Name:
            NameFull: Babb R
      – PersonEntity:
          Name:
            NameFull: Chen G
      – PersonEntity:
          Name:
            NameFull: Martin J
      – PersonEntity:
          Name:
            NameFull: Huang TT
      – PersonEntity:
          Name:
            NameFull: Erlandson K
      – PersonEntity:
          Name:
            NameFull: Willis MS
      – PersonEntity:
          Name:
            NameFull: Armstrong K
      – PersonEntity:
          Name:
            NameFull: Dreier TM
      – PersonEntity:
          Name:
            NameFull: Ward AB
      – PersonEntity:
          Name:
            NameFull: Davey RA
      – PersonEntity:
          Name:
            NameFull: Pitt MLM
      – PersonEntity:
          Name:
            NameFull: Lipsich L
      – PersonEntity:
          Name:
            NameFull: Mason P
      – PersonEntity:
          Name:
            NameFull: Olson W
      – PersonEntity:
          Name:
            NameFull: Stahl N
      – PersonEntity:
          Name:
            NameFull: Kyratsous CA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 11
              Text: 2018 Nov 22
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 218
            – Type: issue
              Value: suppl_5
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1